I’m not convinced that investors would know the difference between a company trying to improve llms vs taking a new approach. So I don’t think it will stifle investment in other forms of AI research.
I also don’t think they are a dead end overall. They sure aren’t likely to get to agi, but you don’t need agi to be useful.
You have to convince investors why your AI research won’t hit a wall like LLMs are now - they’ve poisoned the term “AI”
They’re a dead end, insofar as they do all they’ll ever be able to; if you can find use for them at their current level, great, but it does not look likely they will be able to do more than they currently can
I’m not convinced that investors would know the difference between a company trying to improve llms vs taking a new approach. So I don’t think it will stifle investment in other forms of AI research.
I also don’t think they are a dead end overall. They sure aren’t likely to get to agi, but you don’t need agi to be useful.
You have to convince investors why your AI research won’t hit a wall like LLMs are now - they’ve poisoned the term “AI”
They’re a dead end, insofar as they do all they’ll ever be able to; if you can find use for them at their current level, great, but it does not look likely they will be able to do more than they currently can